President of the jury

Diogo José Fernandes Homem de Lucena

Diogo José Fernandes Homem de Lucena was born in Lisbon, on 8 March 1949. He is an Electrical Engineer by the Instituto Superior Técnico (1972), with a Master of Science (1976) and a Ph.D. (1978) by the Stanford University.

 

Throughout his academic career he has collaborated with the Instituto Superior Técnico and the Economics Faculty of the Universidade Nova de Lisboa, in which he is a Cathedrated Professor (retired). He was also a Visiting Professor in the Stanford University.

 

His main areas of interest were centred, first, in the Uncertainty and Information Economics and in the Telecommunications Economy, and, afterwards, in the matters of the Welfare State Economics, particularly the financing of Health, Education and Social Security.

 

He was part of the Installing Commission the Economics Faculty of the Universidade Nova de Lisboa, where he was MBA Program Director, President of the Pedagogical, Scientific and Councils and Director. He was a member of the Installing Commission of the Law Faculty of the same University, where he was also the Vice-Dean. He was the President of the Scientific Council of the Social and Human Sciences at the Foundation for Science and Technology. He is a member of the National Education Council.

 

He was elected Academic Correspondent of the Lisbon Sciences Academy, in 2007.

 

He was a consultant and participated in the Advisory Councils of several public and private institutions. He participated in the social organs of various companies and foundations, namely as a Member of the Calouste Gulbenkian Foundation’s Management Board, between January 1999 and January 2014. He is member of the Management Board at the Gulbenkian Institute of Science and Member of the Aljubarrota Foundation’s Directive Council. He is part of the juries for the Pessoa Award and the Sustainable Health Award.


Amílcar Falcão

Amílcar Falcão holds a degree in Pharmaceutical Sciences, PhD and Aggregate in Pharmacy (Pharmacology Specialty) from the University of Coimbra. Full Professor, he is starting 1st of March 2019 Dean of the Coimbra University.

 

It has an extensive scientific productivity where there are about 400 publications (articles, book chapters and summaries in indexed journals) and other scientific communications in the form of posters and oral presentations (several dozen by invitation), overwhelmingly international and subject arbitration. He was the thesis supervisor of 15 master's and 8 doctoral students, and is currently responsible for 9 doctoral theses and 3 master's theses. He is regularly invited to perform the function of reviewer, also belonging to the editorial staff of several scientific journals. He has already received several national and international awards that reinforce the visibility and quality of the work he has been developing throughout his career.

 

Having maintained a strong connection with the pharmaceutical industry throughout his professional career, his collaboration with BIAL Laboratories (Portugal) stands out, participating actively and in a relevant way in his program of development of new medicines. Its contribution is to both non-clinical and clinical trials (biostatistics, pharmacokinetics and pharmacodynamics) and has been involved in more than a hundred studies in total. Included in the portfolio are a set of molecules with special emphasis on Eslicarbazepine Acetate, which was the first Portuguese drug to be marketed (Zebinix®) and, more recently, Opicapone (new medicine for Parkinson's disease, currently in Phase III).

Ana Paula Martins

Ana Paula Martins Silvestre Correia holds a degree in Pharmaceutical Sciences from the Faculty of Pharmacy of the University of Lisbon in 1990. She completed her Masters in Epidemiology at the Faculty of Medical Sciences of the Universidade Nova de Lisboa in 1995 and her Ph.D. in Clinical Pharmacy at the Faculty of Pharmacy of Lisbon in May 2005.

 

It is, since February 2016, Bastonary of the Order of Pharmacists. She is an Assistant Professor of the Faculty of Pharmacy of the University of Lisbon in the Department of Socio-Pharmacy and researcher of iMED.UL (Medicines Research Institute Lisbon University) as a researcher in the area of ​​Pharmacoepidemiology and Pharmacy-social.

 

She has dozens of articles published in national and international journals and participated as author and co-author in chapters of books in the area of ​​Pharmacoepidemiology. She is currently the director of two doctoral projects in the area of ​​monitoring the safety of new drugs and in the field of comparative effectiveness in Oncology.

 

He was Chairman of the Board of the Lisbon Regional General Assembly of the Order of Pharmacists, Member of the Board of the Portuguese Epidemiology Association and President of the Portuguese Society of Clinical Pharmacy and Pharmacotherapy. He was a member of the Health Technology Assessment Task Force of the European Federation Pharmaceutical Industry and Associations (EFPIA) representing APIFARMA. He is a member of the Board of the Portuguese Association of Epidemiology.

 

Since March 2015, he has been an alternate member of the National Council of Ethics for Life Sciences (Resolution of the Assembly of the Republic 22-2015 of March 22).


Helena Garrido

Helena Garrido is a journalist, deputy director of information at RTP (Rádio e Televisão de Portugal) and Professor of Economics Journalism at the Lusófona University of Humanities and Technologies. She began her career as a journalist in 1987. She is graduated in Economics from the Faculty of Economics of the Nova University of Lisbon and a Master's Degree in Applied Economics.

 


Jorge Moreira Gonçalves

Jorge Moreira Gonçalves is Professor of Pharmacology at the Faculty of Pharmacy of the University of Porto (U.Porto).

 

He graduated in Pharmaceutical Sciences from the Faculty of Pharmacy of the U.Porto, having a PhD in 1991, at the same University, in Pharmacology. As a postdoctoral fellow, he was a fellow of the Alexander von Humboldt Foundation at the Institut für Pharmakologie und Toxikologie, Universität Freiburg.

 

His scientific areas of interest are cellular communication, specializing in neurotransmission and the development of communication and signal transcription models using transformed yeasts. His scientific production is published internationally in scientific articles and book chapters, published in the main scientific journals of his area of ​​expertise.

 

He was director of the Laboratory of Pharmacology of the Faculty of Pharmacy of U.Porto between 1995 and 2005 and Director of this Faculty between 2002 and 2005. Within these functions, he emphasizes his involvement in the start up and development of the project for the new facilities of the Faculty of Pharmacy and the coordination of the processes of evaluation and credit of the course of Degree in Pharmaceutical Sciences, by the Portuguese Universities Foundation and by the Pharmacists Order, respectively.

 


José Eduardo Soares Moniz

José Eduardo Soares Moniz de Lucena was born in Ponta Delgada on May 6, 1952.

 

Academic training:

 

• Secondary School: National High School of Ponta Delgada

 

• Degree: German Philology, Faculty of Arts of the University of Lisbon

 

• Frequency of seminars abroad

Miguel Gouveia

Miguel Gouveia is Professor in the Catholic Lisbon School of Business and Economics. He received his Ph.D. in Economics from the University of Rochester after a degree in Economics from the Portuguese Catholic University. He teaches in the areas of Health Economics, Economic Analysis of Social Policies and Public Economy. He was a consultant to the World Bank and several public and private institutions in Portugal. He was a member of the Commission on the White Paper on Social Security, Chairman of the Evaluation Committee of Hospitals SA and coordinated the working group that made the assessment of the budgetary impact of the creation of Family Health Units. Has published research in the area of Health Economics with emphasis on the economic evaluation of health technologies.


Paulo Barradas Rebelo

Paulo Barradas Rebelo holds a degree in Pharmaceutical Sciences from the Faculty of Pharmacy of the University of Coimbra in 1993. Graduated in Pharmaceutical Management from Universidade Católica in 2001 and INSEAD's M & As and Corporate Strategy program in 2013.

 

He was Technical Director and Owner of Pharmacy in the Central Region of the Country for 10 years and President of the Direction of Farbeira - Cooperativa de Farmacêuticos do Centro, CRL and Manager of Farmoeste - Distribuidora Farmacêutica do Oeste, Lda. From 1998 to 2001.

 

In 2001, he led a group of professionals who founded Bluepharma - Indústria Farmacêutica, S.A. and acquired the manufacturing facilities of the multinational Bayer in Coimbra. It stood out for the role played in the company's turn-around process, actively contributing to the maintenance of a technology-based strategic sector in Portugal, with an increase in the number of employees, market share and improved profitability.

 

Bluepharma was the first pharmaceutical company in Portugal to obtain the triple integrated certification in Quality, Environment, Occupational Health and Safety and is also certified by EMAS and the Food and Drug Administration (FDA). Its investments in Innovation, Investment, Internationalization and Quality have also been recognized with several prizes, the most recent being the COTEC-BPI SME Innovation Award 2012, the Insead Entrepreneurship Award 2012, Portugal Ventures' Oustanding Venture of the Year 2013 and the PME Excellence Award 2013. As a result of the partnership with the University of Coimbra, Bluepharma launched spin-offs - Luzitin, SA, Treat U, SA and BSim2, Lda.


Paulo Duarte

Paulo Jorge Cleto Duarte, graduated in Pharmaceutical Sciences in 1997 from the Faculty of Pharmacy of the University of Lisbon.

 

He is co-owner of Estacio Pharmacy and Estacio Xabregas Pharmacy, both in Lisbon.

 

He holds an MBA in Information Management from Universidade Católica Portuguesa (2004).

 

He has been President of the Board of the National Association of Pharmacies since 2013.

 

Since 2010, he has been a member of the Board of Directors and Executive Committee of Farminveste.

 

He was secretary general of the National Association of Pharmacies from 2002 to 2013.

 

He was, from 2002 to 2015, Secretary General of the Association of Pharmacists of Portuguese Speaking Countries (AFPLP).

 

From 1999 to 2002 he was secretary general of the Order of Pharmacists.

 

From 1997 to 1999 he was secretary-technician of the National Commission Against AIDS.

 

He began his professional career in 1996 at Johnson & Johnson, with whom he collaborated until 1998 in the regulatory area.


Paulo Gonçalves

Paulo Gonçalves is a Partner at BCG (The Boston Consulting Group) since 2011, and is currently responsible for Health in Iberia. He joined BCG in 2001 in the Lisbon office and from 2005 to 2010 he was in the Madrid office. Since 2011 he has been in Barcelona, ​​being responsible for the local BCG office.

 

Its activity in the area of ​​Health develops in different sectors, from the pharmaceutical company, to the patient associations, through the activity of health care and the distribution of medicines at the warehouse and pharmacy level. During the 13 years of experience in Health Consultancy, he has developed more than 200 projects for the sector, covering different themes, with concrete experience in designing and supporting the implementation of innovative marketing and market access mechanisms for pharmaceutical products and services. as in the evaluation and support to the decision of investment in different situations. In his experience there are also some projects in the area of ​​specialized and general retail.

 

He holds a degree in Pharmaceutical Sciences from the Faculty of Pharmacy of the University of Lisbon and holds an MBA from Universidade Católica. Before BCG worked for 5 years in the Commercial area (Sales, Market Research and Marketing) in different companies of the pharmaceutical sector. She is fluent in Portuguese, English and Spanish, and has a reasonable understanding of Catalan and French.

Rogério Gaspar

Rogério Gaspar is Professor of the Faculty of Pharmacy of the University of Lisbon (FFUL).

 

He is also the Director of the Institute for Interdisciplinary Research (3Is) of the University of Lisbon. Represents externally the University of Lisbon in several institutions of science, technology and entrepreneurship.

 

Until the beginning of his duties as Vice-Rector of the University of Lisbon (on July 25, 2013), he served as Deputy Director of the FFUL (since September 2012, with responsibility for research and international relations), in addition to being a member of the Scientific Council and Faculty Assembly. Between 2008 and 2013 he was also a member of the General Council of the University of Lisbon.

 

Graduated in Pharmaceutical Sciences (specialty of Industrial Pharmacy, July 1985), Doctorate in Pharmaceutical Sciences (Université Catholique de Louvain, June 1991), Aged in Pharmacy by the University of Coimbra (January 1999). His academic career was developed in the Universities of Coimbra (from 1985 to 2006), Católica de Louvaina (where he did doctorate between 1987 and 1991) and Lisbon (since February 8, 2006).

 

He was previously the coordinator of the Department of Galenic Pharmacy and Pharmaceutical Technology of the FFUL (between 2007 and 2013) and the research group "Nanomedicine & Drug Delivery Systems" (iMed.UL, 2007-2013). He also co-ordinated the IntraCell_ADD (Intracellular Trafficking Modulation for Advanced Drug Delivery) group at iMed.ULisboa in 2013 and 2014.